Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5773673

O=C(CCc1cnoc1-c1ccc(F)cc1)N1CCC(N2CCCCC2)CC1.O=C(O)C(F)(F)F

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.43
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
ALDH1A1 P00352 3/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
MAPT P10636 3/20 0.43
TDP1 Q9NUW8 2/20 0.43
SIGMAR1 Q99720 1/20 0.42
ACHE P22303 1/20 0.41
L3MBTL3 Q96JM7 1/20 0.40
CYP3A4 P08684 1/20 0.39
GAA P10253 1/20 0.38
CBX7 O95931 1/20 0.37
CDYL2 Q8N8U2 1/20 0.37
CDYL Q9Y232 1/20 0.37
CDY1; CDY1B Q9Y6F8 1/20 0.37
LMNA P02545 3/20 0.37
ALOX15 P16050 1/20 0.37
TSHR P16473 1/20 0.37
MAPK1 P28482 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5777361 0.99 MAPT (0.44) KDM4EMEN1KMT2AALDH1A1L3MBTL1
SCHEMBL5776036 0.84 LMNA (0.46) KDM4EMEN1KMT2AALDH1A1MAPT
SCHEMBL5774738 0.84 LMNA (0.46) KDM4EMEN1KMT2AALDH1A1MAPT
SCHEMBL5773468 0.84 LMNA (0.46) KDM4EMEN1KMT2AALDH1A1MAPT
Trifluoroacetic Acid SCHEMBL5776834 0.83 HTT (0.46) KMT2AMAPTLMNAHPGD
Trifluoroacetic Acid SCHEMBL5777433 0.82 GFER (0.53) MEN1KMT2AALDH1A1MAPTGAA
SCHEMBL5771554 0.82 GRIN2B (0.40) KDM4EMEN1KMT2AALDH1A1MAPT
Trifluoroacetic Acid SCHEMBL5776847 0.81 MDM2 (0.39) MEN1KMT2AALDH1A1L3MBTL1MAPT
Trifluoroacetic Acid SCHEMBL5772964 0.81 TSHR (0.45) KDM4EMEN1KMT2ACYP3A4TSHR
Trifluoroacetic Acid SCHEMBL5772610 0.81 GFER (0.53) MEN1KMT2AMAPTLMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060084690-A1 Isoxazole derivatives MOMOSE YU 2006-04-20 US disclosed
US-7022725-B2 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-04-04 US disclosed
US-20040048908-A1 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-03-11 US disclosed
EP-1340749-A1 ISOXAZOLE DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2003-09-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060084690-A1 Isoxazole derivatives INSR, GPR119, INSRR KDM4E 3953/4885MEN1 2811/4885KMT2A 3907/4885
US-20040048908-A1 Isoxazole derivatives GPR119, INSR, IRS1 KDM4E 3347/4885MEN1 2072/4885KMT2A 2906/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.